12.30
前日終値:
$12.21
開ける:
$11.98
24時間の取引高:
361.58K
Relative Volume:
0.81
時価総額:
$333.58M
収益:
$157.75M
当期純損益:
$-29.73M
株価収益率:
-10.60
EPS:
-1.16
ネットキャッシュフロー:
$-21.00M
1週間 パフォーマンス:
-17.67%
1か月 パフォーマンス:
-5.31%
6か月 パフォーマンス:
-27.52%
1年 パフォーマンス:
-43.00%
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
名前
Arcturus Therapeutics Holdings Inc
セクター
電話
(858) 900-2660
住所
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
ARCT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ARCT
Arcturus Therapeutics Holdings Inc
|
12.30 | 331.14M | 157.75M | -29.73M | -21.00M | -1.16 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-28 | 開始されました | Scotiabank | Sector Outperform |
2025-01-28 | 開始されました | BTIG Research | Buy |
2024-08-12 | 開始されました | Leerink Partners | Outperform |
2023-12-13 | 開始されました | Canaccord Genuity | Buy |
2023-07-24 | 開始されました | William Blair | Outperform |
2023-05-11 | アップグレード | H.C. Wainwright | Neutral → Buy |
2022-11-14 | 再開されました | Wells Fargo | Overweight |
2022-11-10 | ダウングレード | Robert W. Baird | Neutral → Underperform |
2022-11-03 | アップグレード | Citigroup | Neutral → Buy |
2022-11-02 | アップグレード | Barclays | Underweight → Equal Weight |
2022-08-10 | ダウングレード | Raymond James | Mkt Perform → Underperform |
2022-07-19 | 再開されました | Cantor Fitzgerald | Overweight |
2022-05-11 | アップグレード | Robert W. Baird | Underperform → Neutral |
2022-04-21 | ダウングレード | Citigroup | Buy → Neutral |
2022-01-31 | アップグレード | Raymond James | Underperform → Mkt Perform |
2021-08-12 | ダウングレード | Raymond James | Mkt Perform → Underperform |
2021-08-11 | ダウングレード | Goldman | Neutral → Sell |
2021-08-10 | ダウングレード | Robert W. Baird | Neutral → Underperform |
2021-07-02 | 開始されました | Cantor Fitzgerald | Overweight |
2021-06-25 | 再開されました | Goldman | Neutral |
2021-06-21 | ダウングレード | Barclays | Equal Weight → Underweight |
2021-06-04 | 再開されました | Robert W. Baird | Neutral |
2021-02-17 | ダウングレード | B. Riley Securities | Neutral → Sell |
2021-01-19 | ダウングレード | B. Riley Securities | Buy → Neutral |
2021-01-15 | ダウングレード | B. Riley Securities | Buy → Neutral |
2021-01-07 | 開始されました | Wells Fargo | Overweight |
2020-12-29 | ダウングレード | Barclays | Overweight → Equal Weight |
2020-12-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2020-12-29 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2020-12-29 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2020-12-23 | ダウングレード | ROTH Capital | Buy → Sell |
2020-12-08 | 繰り返されました | B. Riley Securities | Buy |
2020-12-07 | 繰り返されました | B. Riley Securities | Buy |
2020-10-26 | 開始されました | Barclays | Overweight |
2020-10-06 | 開始されました | Citigroup | Buy |
2020-08-26 | 開始されました | Piper Sandler | Overweight |
2020-07-30 | 再開されました | ROTH Capital | Buy |
2020-07-16 | 開始されました | Raymond James | Outperform |
2020-07-13 | 開始されました | B. Riley FBR | Buy |
2020-06-09 | ダウングレード | WBB Securities | Buy → Hold |
2020-02-11 | 開始されました | Robert W. Baird | Outperform |
2020-02-07 | 開始されました | Guggenheim | Buy |
2020-02-06 | 開始されました | Guggenheim | Buy |
2019-04-05 | 開始されました | H.C. Wainwright | Buy |
2018-09-20 | アップグレード | WBB Securities | Buy → Strong Buy |
2018-01-22 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Arcturus Therapeutics Holdings Inc (ARCT) 最新ニュース
Is Arcturus Therapeutics Holdings Inc. stock overvalued or undervaluedHigh-yield portfolio picks - jammulinksnews.com
What is the risk reward ratio of investing in Arcturus Therapeutics Holdings Inc. stockRapid return acceleration - jammulinksnews.com
How does Arcturus Therapeutics Holdings Inc. compare to its industry peersFree Risk Assessment Services - jammulinksnews.com
What are analysts’ price targets for Arcturus Therapeutics Holdings Inc. in the next 12 monthsBuild a winning investment portfolio - jammulinksnews.com
When is Arcturus Therapeutics Holdings Inc. stock expected to show significant growthDiscover breakthrough stocks before the crowd - jammulinksnews.com
Is Arcturus Therapeutics Holdings Inc. a growth stock or a value stockGet professional guidance for market timing - jammulinksnews.com
What catalysts could drive Arcturus Therapeutics Holdings Inc. stock higher in 2025Get alerts on high-potential stock breakouts - jammulinksnews.com
What drives Arcturus Therapeutics Holdings Inc. stock priceAchieve rapid financial growth with smart picks - jammulinksnews.com
What is Arcturus Therapeutics Holdings Inc. company’s growth strategyTremendous financial leverage - jammulinksnews.com
What are Arcturus Therapeutics Holdings Inc. company’s key revenue driversRapid return acceleration - jammulinksnews.com
Investors Don't See Light At End Of Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Tunnel - 富途牛牛
High Growth US Tech Stocks To Watch In August 2025 - simplywall.st
Can Arcturus Therapeutics Holdings Inc. hit a new high this monthWeekly Stock Opportunity Radar Scanner Activated - metal.it
Is Arcturus Therapeutics Holdings (NASDAQ:ARCT) Weighed On By Its Debt Load? - simplywall.st
Why is Arcturus Therapeutics Holdings Inc. stock attracting strong analyst attentionBeginner Investor Report With Low Risk - jammulinksnews.com
Arcturus Therapeutics Holdings Inc. Sees Relief Buying After Extended DropValue Investing Picks With Stability Outlined - beatles.ru
Published on: 2025-07-29 23:05:26 - metal.it
Sector ETF Data Correlates with Strength in Arcturus Therapeutics Holdings Inc.Investment Playbook for Growing Markets Shared - metal.it
Using R and stats models for Arcturus Therapeutics Holdings Inc. forecastingFree Real-Time Analysis With Entry Targets - Newser
Price Floor Holding on Arcturus Therapeutics Holdings Inc. — Rebound PossibleSmart Investment Tips Gaining Popularity Among Analysts - metal.it
How Arcturus Therapeutics Holdings Inc. stock performs during market volatilityCapital Growth Summary Over Five Years - Newser
Arcturus Therapeutics Holdings Inc. Shows Risk Reward Favoring UpsideGrowth Focused Entry Plan Suggestions Issued - metal.it
Does Arcturus Therapeutics Holdings Inc. stock perform well during market downturnsFree Stock Market Real-Time Monitoring - jammulinksnews.com
Why Arcturus Therapeutics Holdings Inc. stock attracts strong analyst attentionTrading Volume Anomaly Summary and Insight - Newser
New York State Common Retirement Fund Sells 1,100 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World
What makes Arcturus Therapeutics Holdings Inc. stock price move sharplyBuild wealth steadily with proven strategies - jammulinksnews.com
Arcturus Therapeutics Holdings Inc. Stock Support and Resistance Levels You Should KnowFree Stock Market Swing Trading Strategies - metal.it
Is Arcturus Therapeutics Holdings Inc. Stock Overbought or Oversold RSI Indicator AnalysisMinimized Risk Maximum Return - Newser
What institutional investors are buying Arcturus Therapeutics Holdings Inc. stockInvest confidently with data-driven strategies - jammulinksnews.com
Is Arcturus Therapeutics Holdings Inc. a good long term investmentFree Investment Community - PrintWeekIndia
Does Arcturus Therapeutics Holdings Inc. stock pay reliable dividendsOutstanding capital returns - jammulinksnews.com
What analysts say about Arcturus Therapeutics Holdings Inc. stockExceptional trading performance - PrintWeekIndia
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 - BioSpace
Arcturus Therapeutics Holdings Inc. Stock Analysis and ForecastTriple-digit wealth increases - Autocar Professional
Arcturus Therapeutics Holdings Inc (ARCT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):